Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathias Heikenwalder

Showing results (241-250 of 263) with videos related to

Pageof 27
Sort By:
Journal of Hepatology|May 16, 2021
Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitisRoser Pinyol, Sara Torrecilla, Huan Wang, et al.
Journal of Hepatology|October 10, 2021
Corrigendum to 'Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis' [J Hepatol 75 (2021) 865-878]Roser Pinyol, Sara Torrecilla, Huan Wang, et al.
Signal Transduction and Targeted Therapy|March 3, 2026
Harnessing lipid-driven immunometabolic pathways in omental metastases to enhance immunotherapy in patients with ovarian cancerMeggy Suarez-Carmona, Mareike Hampel, Xin-Wen Zhang, et al.
The EMBO Journal|March 25, 2021
Neutrophils induce paracrine telomere dysfunction and senescence in ROS-dependent mannerAnthony Lagnado, Jack Leslie, Marie-Helene Ruchaud-Sparagano, et al.
Cancer Cell|September 19, 2019
Age-Related Gliosis Promotes Central Nervous System Lymphoma through CCL19-Mediated Tumor Cell RetentionTracy O'Connor, Xiaolan Zhou, Jan Kosla, et al.
Journal of Hepatology|December 21, 2024
Single-cell RNA sequencing-derived signatures define response patterns to atezolizumab + bevacizumab in advanced hepatocellular carcinomaSarah Cappuyns, Marta Piqué-Gili, Roger Esteban-Fabró, et al.
Journal for Immunotherapy of Cancer|October 6, 2025
Preliminary qualification of a machine learning-based assessment of the tumor immune infiltrate as a predictor of outcome in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumabBernhard Scheiner, Pasquale Lombardi, Antonio D'Alessio, et al.
Cancer Cell|June 14, 2017
Kupffer Cell-Derived Tnf Triggers Cholangiocellular Tumorigenesis through JNK due to Chronic Mitochondrial Dysfunction and ROSDetian Yuan, Shan Huang, Emanuel Berger, et al.
Cancer Cell|July 4, 2025
Age-Related Gliosis Promotes Central Nervous System Lymphoma through CCL19-Mediated Tumor Cell RetentionTracy O'Connor, Xiaolan Zhou, Jan Kosla, et al.
Nature Reviews. Gastroenterology & Hepatology|December 10, 2025
Cholangiocarcinoma 2026: status quo, unmet needs and prioritiesJesus M Banales, Pedro M Rodrigues, Silvia Affò, et al.
Pageof 27

Showing results (241-250 of 263) with videos related to

Sort By:
Pageof 27
Journal of Hepatology|May 16, 2021
Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitisRoser Pinyol, Sara Torrecilla, Huan Wang, et al.
Journal of Hepatology|October 10, 2021
Corrigendum to 'Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis' [J Hepatol 75 (2021) 865-878]Roser Pinyol, Sara Torrecilla, Huan Wang, et al.
Signal Transduction and Targeted Therapy|March 3, 2026
Harnessing lipid-driven immunometabolic pathways in omental metastases to enhance immunotherapy in patients with ovarian cancerMeggy Suarez-Carmona, Mareike Hampel, Xin-Wen Zhang, et al.
The EMBO Journal|March 25, 2021
Neutrophils induce paracrine telomere dysfunction and senescence in ROS-dependent mannerAnthony Lagnado, Jack Leslie, Marie-Helene Ruchaud-Sparagano, et al.
Cancer Cell|September 19, 2019
Age-Related Gliosis Promotes Central Nervous System Lymphoma through CCL19-Mediated Tumor Cell RetentionTracy O'Connor, Xiaolan Zhou, Jan Kosla, et al.
Journal of Hepatology|December 21, 2024
Single-cell RNA sequencing-derived signatures define response patterns to atezolizumab + bevacizumab in advanced hepatocellular carcinomaSarah Cappuyns, Marta Piqué-Gili, Roger Esteban-Fabró, et al.
Journal for Immunotherapy of Cancer|October 6, 2025
Preliminary qualification of a machine learning-based assessment of the tumor immune infiltrate as a predictor of outcome in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumabBernhard Scheiner, Pasquale Lombardi, Antonio D'Alessio, et al.
Cancer Cell|June 14, 2017
Kupffer Cell-Derived Tnf Triggers Cholangiocellular Tumorigenesis through JNK due to Chronic Mitochondrial Dysfunction and ROSDetian Yuan, Shan Huang, Emanuel Berger, et al.
Cancer Cell|July 4, 2025
Age-Related Gliosis Promotes Central Nervous System Lymphoma through CCL19-Mediated Tumor Cell RetentionTracy O'Connor, Xiaolan Zhou, Jan Kosla, et al.
Nature Reviews. Gastroenterology & Hepatology|December 10, 2025
Cholangiocarcinoma 2026: status quo, unmet needs and prioritiesJesus M Banales, Pedro M Rodrigues, Silvia Affò, et al.
Pageof 27